Navigation Links
CardioGenics to File for 510K Clearance With the United States Food and Drug Administration by Q4 2011
Date:2/3/2011

MISSISSAUGA, Ontario, Feb. 3, 2011 /PRNewswire/ -- CardioGenics Holdings Inc. (CGNH.OB) announced today final plans for testing of its QL Care™ (QLCA) Analyzer. The data that will be collected from the testing at 4 hospitals in North America will be used as a key component of the Company's 510K application with the United States Food and Drug Administration. The 510K application will allow the FDA to determine whether the QLCA is equivalent to another device that is currently approved by the FDA for commercialization.  Upon approval of the application, CardioGenics will begin marketing the QLCA throughout the United States.

The Company has determined that it will use the Siemens ADVIA Centaur Analyzer and its related Troponin-I test as the reference standard for its clinical testing. CardioGenics has already identified four hospitals that use the Siemens ADVIA Centaur and will obtain approval from these hospitals to conduct comparative clinical testing of its QL Care™ Analyzer and Troponin-I test at their sites. The goal of this comparative testing is to confirm that the results from the CardioGenics QL Care™ Analyzers and the Siemens ADVIA Centaur systems are equivalent. CardioGenics expects to begin enrolling patients in this comparative trial upon approval of the Institutional Review Boards, which approvals it expects to receive by May 2011. The comparative trials will take approximately 45 days to complete.

Upon successful completion of clinical confirmation, the Company will then finalize protocols and commence trials for the FDA application for approval of its QL Care™ Analyzer and Troponin-I test. This final testing is expected to start during early Q3 2011 and complete two months later.

Yahia Gawad, MD, Chief Executive Officer of CardioGenics Holdings Inc. said, "Over the past few months, we have completed development of the QL Care™ Analyzer. We have solved many of the technological challenges that
'/>"/>

SOURCE CardioGenics Holdings Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CardioGenics Holdings Inc. Provides Update on FINRA Submission Regarding Name Change
2. CardioGenics Holdings Inc. Announces Letter to Shareholders
3. CardioGenics Announces Completion of Cartridge Design for QL Care Analyzer
4. CardioGenics Holdings Inc. Featured in Medical Device Daily
5. Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive
6. CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads
7. CardioGenics Announces Further Update Regarding Status of Merck Agreement
8. CardioGenics Announces Lock-Up Agreement with Dr. Yahia Gawad
9. CardioGenics to be Spotlighted in Three Publications During Month of April
10. CardioGenics Announces Update Regarding Status of Merck Agreement
11. CardioGenics Announces Reverse Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014  Elusys Therapeutics, ... to treat infectious disease, today announced it has ... studies of obiltoxaximab (ETI-204). Obiltoxaximab is an anti-toxin ... and data from these studies support the safety ... (IV) at the intended therapeutic dose. The conclusion ...
(Date:9/22/2014)...  Aethlon Medical, Inc. (OTCQB: AEMD), the pioneer ... disease, cancer and other life-threatening conditions, disclosed today ... has informed the Company that it plans to ... of a five-year $5.9 million contract that was ... DARPA,s Dialysis-Like Therapeutics (DLT) program. The ...
(Date:9/22/2014)... 2014 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or ... quality medical marijuana products, is pleased to announce that ... signed a definitive lease agreement for a second facility ... facility has 28,966 square feet of floor space with ... mezzanine space for a total of approximately 43,500 square ...
Breaking Medicine Technology:Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 4Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 5Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 6Aethlon Medical Receives Notice of DARPA Contract Renewal 2Aethlon Medical Receives Notice of DARPA Contract Renewal 3Aethlon Medical Receives Notice of DARPA Contract Renewal 4T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 2T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 3
...  PAREXEL International Corporation (NASDAQ: PRXL ) today ... March 31, 2012. For the three months ... by 18.1% to $356.0 million compared with $301.4 million ... negative impact from foreign exchange on consolidated service revenue ...
... Mass., April 29, 2012  Haemonetics Corporation (NYSE: ... acquire the business assets of the blood collection, filtration ...  Blood processing systems and equipment to be acquired are ... facilities in Covina, California; Tijuana, Mexico; Ascoli, Italy and ...
Cached Medicine Technology:PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 2PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 3PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 4PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 5PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 6PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 7PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 8PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 9PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 10PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 11PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 12PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 13Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 2Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 3Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 4Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 5
(Date:9/23/2014)... Recently, BuyTopDress.com, a popular supplier of wedding dresses and special ... fashionable marine ball dresses . Along with this, the ... brand new items; all of them are now provided with ... now, BuyTopDress.com has won more than 2000 happy customers in ... its products and after-sale services. The company is offering thousands ...
(Date:9/22/2014)... September 23, 2014 The Gesundheit! Institute ... a new design and restructuring for their existing website. The ... grown. They needed a way to navigate to the different ... well as present the look and feel of the site ... In 1971, when Patch Adams graduated from The Medical School ...
(Date:9/22/2014)... leather seat covers offered by Lseat.com are meticulously in ... to meet customers’ specific product needs and budget level. The ... leather seat covers . Furthermore, the firm has launched an ... the new range is now available at a discounted rate ... are produced, the company’s top designers also carefully pick out ...
(Date:9/22/2014)... Career Step, an online provider of ... and exhibiting at the 86th Annual Convention and ... (AHIMA) in San Diego, California. The conference is ... Career Step will be exhibiting in booth 711 ... products, including CLiM™, its coder lifecycle management solution, ...
(Date:9/22/2014)... Marietta, GA (PRWEB) September 23, 2014 The ... staff are helping to promote National Breast Cancer Awareness ... intend to contribute awareness to cause, prevention, diagnosis, treatment and ... in dental offices across the U.S. , A pink ... the person that can tell us why the Sonicare is ...
Breaking Medicine News(10 mins):Health News:Fashionable Marine Ball Dresses Added To BuyTopDress.com’s Collection 2Health News:Idea Marketing Group Launches a New Website for The Gesundheit! Institute 2Health News:Idea Marketing Group Launches a New Website for The Gesundheit! Institute 3Health News:Great 2007-2012 Jeep Wrangler JK Real Leather Seat Covers Introduced by Lseat.com 2Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2Health News:Verde Pointe Dental Associates Participate in Breast Cancer Awareness Month 2014 with a Pink Philips Sonicare Giveaway 2
... ... workplace culture to empower professional women to breastfeed , ... Sacramento, CA (PRWEB) May 10, 2010 -- Is the primitive fear ... ,That is one premise a California startup, Dao Health, is contributing to the public conversation ...
... ill and participate in mild exercise programs led by ... days in intensive care units (ICU) and hospitals than ... published in the April issue of the Archives ... quality improvement project implemented in a medical intensive care ...
... physical abuse alone, study found , MONDAY, May 10 (HealthDay ... women who are exposed to physical and verbal abuse have ... up in the results, study author Dr. Charles P. Mouton ... physical abuse alone. , Why? "The physical abuse may be ...
... pressure are at even greater risk, study finds ... have fluctuating blood pressure in addition to high blood ... research shows. , Cerebrovascular disease, which includes stroke and ... associated with disability and a decline in memory and ...
... sibling has the movement disorder, study shows , MONDAY, May ... who have restless legs syndrome are also more likely to ... authors of the study, which is published in the May ... will raise awareness of the condition for both physicians and ...
... The lawsuit, ... some 30,000 health care workers, treats visiting nurses and other health care providers as exempt ... hours worked. , ... NY (PRWEB) May 10, 2010 -- A nationwide class action lawsuit was filed ...
Cached Medicine News:Health News:Is Fear of Being Caught Naked an Obstacle to Increasing Breastfeeding Rates? 2Health News:Is Fear of Being Caught Naked an Obstacle to Increasing Breastfeeding Rates? 3Health News:Is Fear of Being Caught Naked an Obstacle to Increasing Breastfeeding Rates? 4Health News:Physical therapist-led exercise in patients in ICU improves function and decreases hospital stay 2Health News:Older, Abused Women Suffer Poor Mental Health 2Health News:Fluctuating Blood Pressure Ups Stroke Risk 2Health News:Restless Legs Syndrome Can Have Family Ties 2Health News:Martin & Jones Announces Class Action Lawsuit Against Major Employer, Claims Thousands of Visiting Nurses Illegally Denied Overtime Pay 2Health News:Martin & Jones Announces Class Action Lawsuit Against Major Employer, Claims Thousands of Visiting Nurses Illegally Denied Overtime Pay 3
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTP/1Q-PAL chairs are recommended for the ... room, static control, health care and ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTP/1Q-PAL chairs are recommended for the ... room, static control, health care and ...
... with concave seats and standard-sized backrests ... like seats, backrests, armrests, and casters ... recommended for the following environments: industry, ... health care and office. • With ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTN/1Q-CAB chairs are recommended for the ... room, static control, health care and ...
Medicine Products: